Literature DB >> 4492776

Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.

D T Durack, L L Pelletier, R G Petersdorf.   

Abstract

Bacterial endocarditis was produced by intravenous injection of Streptococcus viridans into rabbits with preexisting sterile endocardial vegetations. After 6 h had elapsed, bacteria in the vegetations could not be eradicated by brief treatment with antimicrobials to which the streptococci were sensitive. However, when treatment with penicillin was continued for 4 days, the animals were cured. The 6-h infection therefore offered a model in which treatments could be conveniently compared over a short period. Synergism was demonstrated between penicillin and streptomycin in endocarditis due to a fully penicillin-sensitive streptococcus, a point which had not been previously proved in vivo. The clinical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4492776      PMCID: PMC333064          DOI: 10.1172/JCI107622

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  Successful short-term therapy of streptococcal endocarditis with penicillin and streptomycin.

Authors:  B HALL; H F DOWLING; W KELLOW
Journal:  Am J Med Sci       Date:  1955-07       Impact factor: 2.378

2.  The antibiotic therapy of bacterial endocarditis: therapeutic data on 172 patients seen from 1951 through 1957: additional observations on short-term therapy (two weeks) for penicillin-sensitivie streptococcal endocarditis.

Authors:  J E GERACI
Journal:  Med Clin North Am       Date:  1958-07       Impact factor: 5.456

3.  The bactericidal action of streptomycin.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1948-02-28

4.  The treatment of some bacterial infections of the heart and pericardium.

Authors:  T H HUNTER
Journal:  Bull N Y Acad Med       Date:  1952-04

5.  Successful two-week treatment schedule for penicillin-susceptible streptococcus viridans endocarditis.

Authors:  J S Tan; S Kaplan; C A Terhune; M Hamburger
Journal:  Lancet       Date:  1971-12-18       Impact factor: 79.321

6.  Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits.

Authors:  D T Durack; P B Beeson; R G Petersdorf
Journal:  Br J Exp Pathol       Date:  1973-04

7.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

9.  Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart.

Authors:  P K Garrison; L R Freedman
Journal:  Yale J Biol Med       Date:  1970-06
  9 in total
  16 in total

1.  Synergism and antagonism among antimicrobial drugs. A personal perspective.

Authors:  E Jawetz
Journal:  West J Med       Date:  1975-08

2.  Editorials: Combination antimicrobial therapy.

Authors:  R G Petersdorf
Journal:  West J Med       Date:  1975-08

Review 3.  [Infective endocarditis : Update on prophylaxis, diagnosis, and treatment].

Authors:  S Dietz; H Lemm; M Janusch; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-10       Impact factor: 0.840

4.  Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics.

Authors:  P R Meylan; P Francioli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

5.  In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.

Authors:  R C Owens; M A Banevicius; D P Nicolau; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Value of serum tests in combined drug therapy of endocarditis.

Authors:  T A Drake; C J Hackbarth; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Antimicrobial therapy of streptococcal endocarditis.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267

8.  Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits.

Authors:  J Carrizosa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

9.  Natural history of aortic valve endocarditis in rats.

Authors:  E Héraïef; M P Glauser; L R Freedman
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.

Authors:  B Pangon; V Joly; J M Vallois; L Abel; A Buré; N Brion; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.